Volume 24, Number 3—March 2018
Research
Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
Table 1
Characteristic | Value |
---|---|
Age, y, median (IQR) | 47.0 (30.0–61.0) |
Age >60 y |
402 (27.0) |
Sex | |
M | 942 (63.3) |
F |
545 (36.7) |
Race/Ethnicity | |
Non-Hispanic white | 152 (10.2) |
Black | 275 (18.5) |
Hispanic | 762 (51.2) |
Asian | 288 (19.4) |
Other |
10 (0.7) |
Foreign-born | 897 (60.3) |
Resident of long-term care facility | 20 (1.3) |
Homeless | 100 (6.7) |
Excess alcohol user | 257 (17.3) |
Injection drug user |
38 (2.6) |
Chest radiograph result | |
Normal | 160 (10.8) |
Consistent with TB | 1,240 (83.4) |
Unknown/Not done |
87 (5.9) |
TB site | |
Pulmonary | 1,136 (76.4) |
Extrapulmonary | 196 (13.2) |
Both |
155 (10.4) |
HIV status | |
Negative | 1,279 (86.0) |
Positive | 90 (6.1) |
Unknown |
118 (7.9) |
MDR | 13 (0.9) |
Days from diagnosis to treatment, median (IQR) | 3.0 (0–13.0) |
Died within 1 year of TB diagnosis | 105 (7.1) |
*Values are no. (%) unless otherwise indicated. Percentages were calculated on the basis of the number of patients with data available. IGRA, interferon-γ release assay; IQR, interquartile range; MDR, multidrug resistance; TB, tuberculosis.
Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.